Stock listing

gettex:2DT Amneal Pharmaceuticals, Inc. Aktie

German listing (gettex) of Amneal Pharmaceuticals, Inc. · home listing NASDAQ:AMRX

Follow Amneal Pharmaceuticals, Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:AMRX

$19.18 USD -0.07 (-0.4%)

Close on Oct 16, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:AMRX

Since Jul 6, 2026 +13.4% · daily closes, Jul 6, 2026 – Oct 16, 2026, adjusted for splits
Day range
$18.94 – $19.39 USDOct 16, 2026
Volume
2.29M sharesOct 16, 2026
Market value
$6.68B USDAt the close on Oct 16, 2026 · price × 348.3M shares outstanding
Amneal Pharmaceuticals, Inc. logo
Ticker
gettex:2DT
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
gettex
Currency
EUR

What changed lately

Calls

Replays

  • Amneal Pharmaceuticals (NASDAQ:AMRX) Q2 2026 Earnings Call

    Thu, Jul 30, 2026 · 8:30 AM ET

    Watch Transcript

  • Amneal Pharmaceuticals (NASDAQ:AMRX) Q1 2026 Earnings Call

    Fri, May 01, 2026 · 8:30 AM ET

    Watch Transcript

  • Amneal Pharmaceuticals (NASDAQ:AMRX) Q4 2025 Earnings Call

    Fri, Feb 27, 2026 · 8:30 AM ET

    Watch Transcript

Latest news

Amneal to Report Third Quarter 2026 Results on November 3, 2026

Oct 8, 2026

Amneal Announces FDA Approval and Launch of Lanreotide Injection

Sep 18, 2026

Amneal Completes Acquisition Of Kashiv

Aug 17, 2026

Amneal Completes Acquisition of Kashiv BioSciences, Creating a Global Biosimilar Leader

Aug 10, 2026

Amneal Reports Second Quarter 2026 Financial Results

Jul 30, 2026

Amneal Expands Iohexol Injection Portfolio with U.S. FDA Approval of Additional Strengths and Presentations

Jul 17, 2026

Amneal to Report Second Quarter 2026 Results on July 30, 2026

Jul 9, 2026

Dispensary of Hope Launches "Hope Alliance" Campaign with Support from Amneal Pharmaceuticals

Jun 10, 2026

Amneal Announces Full Study Population Interim Phase 4 ELEVATE-PD Results, Reinforcing Previously Reported Benefits of CREXONT® in Parkinson's Disease

Jun 5, 2026

Amneal Announces U.S. FDA Approval of Romidepsin Injection Solution

Jun 4, 2026

All Amneal Pharmaceuticals, Inc. news

Decks

Amneal Pharmaceuticals, Inc. on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
35 in the last 12 months · 182 in all · newest Oct 8, 2026 · oldest 2019
Calls
23 calls with a replay · 23 with a transcript · latest Jul 30, 2026
Decks
54 decks · latest Jul 30, 2026

Where Amneal Pharmaceuticals, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:AMRX · Home listingNASDAQUnited StatesUSD
gettex:2DT · This pagegettexGermanyEUR
LS Exchange:A2JLMDLS ExchangeGermanyEUR
Lang & Schwarz:A2JLMDLang & SchwarzGermanyEUR
Tradegate:2DTTradegateGermanyEUR
BOATS:AMRXBOATSUnited StatesUSD
Frankfurt:2DTFrankfurtGermanyEUR
Dusseldorf:2DTDusseldorfGermanyEUR
Munich:2DTMunichGermanyEUR
Stuttgart:2DTStuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Amneal Pharmaceuticals, Inc.